HHS-OS-JEFO redacted_Redacted.pdf

The contractor will be requested to provide advice and consultation with respect to various pharmaceutical products that are identified by the United States Government; advise as to which manufacturing facility or facilities are capable of manufacturing the products, and will advise as to which raw materials, finished products or chemical, biological, or mechanical components would be required to ensure successful manufacture; and advise the USG as to development and execution of manufacturing plans, and such plans will address how the supply of materials and components may be assured, and how the United States can rapidly ensure that appropriate manufacturing, storage, and distribution capacities are in place.

Requirement type.

Support services (non-research & development) Supplies/equipment Information technology (IT) Other (specify): ____________________

Type of action.

New requirement Follow-on Other (specify): ______________________

Proposed contract/order type.

Firm-fixed-price Time and materials Indefinite delivery (specify whether indefinite quantity, definite quantity, or requirements): ___________ Other (specify): Hybrid FFP and T&M

c. Total estimated dollar value and performance/delivery period.

5-Month base period

4. Identification of the justification rationale [see 16.505(b)(2)(ii)(C)] and, if applicable, a demonstration of the proposed contractor’s unique qualifications to provide the required supply or service.

a. Acquisition authority.

This acquisition is conducted under the authority of an Indefinite Delivery contract. Consideration of contractors will be restricted to fewer than the number required by Federal Acquisition Regulation (FAR) 16.505(b)(1)

This acquisition is conducted under the authority of an Indefinite

Delivery contract. Consideration of contractors will be restricted only to the item peculiar to one manufacturer as provided in FAR 16.505(a)(4).

b. Demonstration of the proposed contractor(s) unique qualifications to provide the required supply or service.

Name and address of the proposed contractor(s).

Advanced Decision Vectors, LLC.

5270 Shawnee Road #104 Alexandria, VA 22312

Nature of the acquisition and proposed contractor(s) unique qualifications.

COVID-19 has presented an unprecedented challenge in U.S. modern history. As this virus spreads throughout the United States the Department of Health and Human Services (HHS) has identified a weakness in our ability to respond with therapeutics, vaccines and diagnostics. We are exercising the authority found in the Federal Acquisition Regulation Part 16.505(b)(2)(i)(A), the agency need for the supplies or services is so urgent that providing a fair opportunity would result in unacceptable delays. Pending the development and deployment of an effective vaccine, most individuals in the country will remain susceptible to this virus. A safe, effective, broadly administered vaccine is the single most important solution to this pandemic.

The Objective of this effort is to assist the HHS maximally expedite the development of a safe and effective vaccine with sufficient scale to inoculate all Americans who need it and enable broad access to the public. The challenges presented by this pandemic require a fundamentally different approach to vaccine development and delivery. The contractor shall perform support services in accordance with the National Institutes of Health Business and Professional Support Services II Statement of Work in support of Department of Health and Human Services efforts related to new COVID-19 vaccine candidates, therapeutics, and diagnostics. The consultants will be requested to provide advice and consultation with respect to various pharmaceutical products that are identified by the United States Government. Consultant will advise as to which manufacturing facility or facilities are capable of manufacturing the products, and will advise as to which raw materials, finished products or chemical, biological, or mechanical components would be required to ensure successful manufacture. Consultant will advise the USG as to development and execution of manufacturing plans, and such plans will address how the supply of materials and components may be assured, and how the United States can rapidly ensure that appropriate manufacturing, storage, and distribution capacities are in place. Any delay in awarding this action causes serious injury to our citizens and hinders